Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. They are focused on becoming the standard of care for spine fusion surgery. They've been using technology and AI-enabled 3D surgical planning and implants personalized for each patient.

Mike Cordonnier is the co-founder and serves as Chief Executive Officer and President of Carlsmed, he also serves as Chairman of the Board of Directors. He speaks with Carol Massar and Tim Stenovec on the company's earnings and commercial & growth strategy.